Correlation of opsonophagocytosis and passive protection assays using human anticapsular antibodies in an infant mouse model of bacteremia for Streptococcus pneumoniae.
about
Modulation of the lung inflammatory response to serotype 8 pneumococcal infection by a human immunoglobulin m monoclonal antibody to serotype 8 capsular polysaccharide.Correlation of molecular characteristics, isotype, and in vitro functional activity of human antipneumococcal monoclonal antibodies.Methodological criticisms in the evaluation of Pneumococcal Conjugate Vaccine effectivenessThe Streptococcus pneumoniae capsule is required for full virulence in pneumococcal endophthalmitisBridging phase 2 and phase 3 pneumococcal immunologic data for future combination vaccines.Discovery of a novel class of highly conserved vaccine antigens using genomic scale antigenic fingerprinting of pneumococcus with human antibodiesAssessment of antibody response elicited by a 7-valent pneumococcal conjugate vaccine in pediatric human immunodeficiency virus infection.Aggregation of Streptococcus pneumoniae by a pneumococcal capsular polysaccharide-specific human monoclonal IgM correlates with antibody efficacy in vivoSpecificities and opsonophagocytic activities of antibodies to pneumococcal capsular polysaccharides in sera of unimmunized young children.Effective combination therapy for invasive pneumococcal pneumonia with ampicillin and intravenous immunoglobulins in a mouse model.Comparison of a classical phagocytosis assay and a flow cytometry assay for assessment of the phagocytic capacity of sera from adults vaccinated with a pneumococcal conjugate vaccine.Are the opsonophagocytic activities of antibodies in infant sera measured by different pneumococcal phagocytosis assays comparable?Functional opsonic activity of human serum antibodies to inner core lipopolysaccharide (galE) of serogroup B meningococci measured by flow cytometry.Immunochemical properties of the staphylococcal poly-N-acetylglucosamine surface polysaccharide.Randomized, single blind, controlled trial to evaluate the prime-boost strategy for pneumococcal vaccination in renal transplant recipients.Passive immunization with Pneumovax® 23 and pneumolysin in combination with vancomycin for pneumococcal endophthalmitis.Type-specific antibodies to pneumococcal capsular polysaccharide acquired either naturally or after vaccination with Prevenar in children with underlying chronic or recurrent lung diseases.Impact of the conjugation method on the immunogenicity of Streptococcus pneumoniae serotype 19F polysaccharide in conjugate vaccines.Comparison of pneumococcal conjugate polysaccharide and free polysaccharide vaccines in elderly adults: conjugate vaccine elicits improved antibacterial immune responses and immunological memory.Pneumococcal vaccination and revaccination of older adults.Trojan horse effect: phagocyte-mediated Streptococcus iniae infection of fishEnzyme-linked immunosorbent assay for quantitation of human antibodies to pneumococcal polysaccharidesFunctional antibodies elicited by two heptavalent pneumococcal conjugate vaccines in the Finnish Otitis Media Vaccine Trial.Effectiveness, immunogenicity and safety of 23-valent pneumococcal polysaccharide vaccine revaccinations in the elderly: a systematic review.Long-term comparative immunogenicity of protein conjugate and free polysaccharide pneumococcal vaccines in chronic obstructive pulmonary disease.Efficacy of opsonic and nonopsonic serotype 3 pneumococcal capsular polysaccharide-specific monoclonal antibodies against intranasal challenge with Streptococcus pneumoniae in mice.Vaccination of adults with 23-valent pneumococcal polysaccharide vaccine induces robust antibody responses against pneumococcal serotypes associated with serious clinical outcomes.Animal models of Streptococcus pneumoniae diseaseSuperior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease.Phagocyte subsets and lymphocyte clonal deletion behind ineffective immune response to Staphylococcus aureus.Streptococcus pneumoniae serotype 19A: Worldwide epidemiology.Pneumococcal conjugate vaccine use in adults.Discrepant serological assays for Pneumococcus in renal transplant recipients - a prospective study.Complex immune correlates of protection in HIV-1 vaccine efficacy trials.Potential impact of a Moraxella catarrhalis vaccine in COPD.Prediction of pneumococcal conjugate vaccine effectiveness against invasive pneumococcal disease using opsonophagocytic activity and antibody concentrations determined by enzyme-linked immunosorbent assay with 22F adsorption.Human antibodies specific for the high-molecular-weight adhesion proteins of nontypeable Haemophilus influenzae mediate opsonophagocytic activityA Semi-synthetic Oligosaccharide Conjugate Vaccine Candidate Confers Protection against Streptococcus pneumoniae Serotype 3 Infection.Approach to validating an opsonophagocytic assay for Streptococcus pneumoniae.Protection against pneumococcal pneumonia in mice by monoclonal antibodies to pneumolysin.
P2860
Q24532019-5C071A3A-F32B-47DE-ABB2-948AFEA02FFAQ24537385-301DC18D-0992-4B5C-807A-D313AD4BAEBEQ26770693-8B3F666F-B9D4-4461-A969-C0A836A58117Q28386753-3A9A28D4-5390-4093-9658-4214195AEDEEQ30665602-16C8764B-44A5-44E4-A503-F6B972A62873Q33312893-EE37C0BF-7263-47D4-9F87-F6BA9C343BCAQ33593822-AF8C7C7E-9425-496B-839E-18F674A33874Q33825652-5206C7AD-74C6-42C7-908C-0A30F71A86E4Q33944443-8FF0537A-A9C9-4A23-B5E7-1A1121604B39Q33981259-2519A81C-6611-4A78-BF01-D1F854268240Q33998938-19528D5D-19D1-46EA-A6D0-FEA3A2ED089EQ33998997-EBE85EC3-C081-4FB1-B462-71A8F84A27D2Q34007332-4E6B20A9-897E-4A39-803A-FB2648928989Q34128193-10BEBFFF-1A4A-4185-A8E9-C43D42F658C2Q34430844-18BF5FD5-E78C-4961-9765-EF316A85AAB3Q34621983-9EEFCD87-D9BE-4E1A-9D9A-F448A1253E26Q34720274-55BDF8E8-9569-4889-8F29-6F47D0B63DA1Q34738780-D62BCF7A-E9FA-4DF5-A55F-D467D8ED6A78Q34774773-739F720C-A80C-4ACA-888C-3120442A9D21Q34926870-8448D2A4-CDE9-424B-9F29-0C97BF81AD86Q34932037-92D1DDC7-4C4C-4ABF-9270-8E9C7B653010Q35139987-74A7A403-5F87-4212-81E7-68C028AABD0BQ35783918-BDF9BE5D-8730-41FE-B389-7FFC8077765AQ36204195-583D6541-032B-4811-A204-65F6FA13545CQ36379580-6AD72BD6-EC43-4E99-8867-63485D4B2540Q37145037-FBB2EC7C-F6E0-467E-9D15-47352C5F81D7Q37197138-F7AB9DFF-786A-4254-9392-A698654FFBD1Q37293669-2BD62462-65F9-427F-9C0F-B45A8B7F633EQ37343744-375513B2-28F2-4D3D-B62A-00E291D9F674Q38494482-0FD68FAE-6F99-4C35-A006-75E588918C89Q38637072-710A3719-F51E-4464-A33C-0C4F45F99F75Q38664425-A9DF9A9A-80B3-46A9-AD22-589904AC1A00Q38739122-DD55D9CA-E1C3-4281-AA11-CB92C8118374Q39108779-67815AD6-54AA-4373-8080-3353CC95BD15Q39129692-6E75B0E5-D342-4A2C-A7FD-042E5EDB3C4BQ39657425-D769D629-3092-49E7-8553-284380A22F73Q40403842-68C31EAA-C895-4EA7-9B77-BCB719A29ADFQ40462015-CD8AD250-2033-41C7-8CF2-26DF61C06440Q41095079-38C18F4B-D849-4A33-9483-28EA7844C6EAQ41195561-39EC6628-3F05-4AA8-836E-92ADC0169D66
P2860
Correlation of opsonophagocytosis and passive protection assays using human anticapsular antibodies in an infant mouse model of bacteremia for Streptococcus pneumoniae.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
1999年學術文章
@zh
1999年學術文章
@zh-hant
name
Correlation of opsonophagocyto ...... for Streptococcus pneumoniae.
@en
Correlation of opsonophagocyto ...... for Streptococcus pneumoniae.
@nl
type
label
Correlation of opsonophagocyto ...... for Streptococcus pneumoniae.
@en
Correlation of opsonophagocyto ...... for Streptococcus pneumoniae.
@nl
prefLabel
Correlation of opsonophagocyto ...... for Streptococcus pneumoniae.
@en
Correlation of opsonophagocyto ...... for Streptococcus pneumoniae.
@nl
P2093
P356
P1476
Correlation of opsonophagocyto ...... for Streptococcus pneumoniae.
@en
P2093
Carlone GM
Johnson SE
P304
P356
10.1086/314845
P407
P577
1999-07-01T00:00:00Z